India Radiotherapy Devices Market By Type (External Beam Radiation Therapy Device, Internal Beam Radiation Therapy Device, Others), By Application (Breast Cancer, Cervical Cancer, Colon and rectum Cancers, Stomach Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Liver Cancer, Other), By End User (Hospitals & Clinics, Cancer Care Centers, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

India Radiotherapy Devices Market was valued at USD 144.20 Million in 2024 and is expected to reach USD 241.45 Million by 2030 with a CAGR of 8.93% during the forecast period.

The India radiotherapy devices market is experiencing significant growth, driven by the increasing prevalence of cancer and advancements in treatment technologies. The demand for precise and effective cancer treatments has led to the rapid adoption of External Beam Radiation Therapy (EBRT) devices, particularly those utilizing advanced techniques like intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and proton therapy.

Government initiatives and investments in healthcare infrastructure are expanding access to radiotherapy services, particularly in metropolitan and emerging urban centers. The market is also supported by the rise in medical tourism, as India becomes a hub for cost-effective cancer treatments.

However, challenges such as the high costs of radiotherapy devices, the need for skilled professionals to operate complex equipment, and the uneven distribution of advanced healthcare facilities across the country continue to hinder the market's potential. Despite these obstacles, increasing awareness of cancer and its early detection, coupled with efforts to enhance the healthcare system's reach, are creating a positive outlook for the market. The demand for advanced radiotherapy solutions is expected to continue rising, particularly as healthcare providers focus on expanding access in underserved regions.

Key Market Drivers

Rising Cancer Prevalence

• The increasing prevalence of cancer in India is a major driver of the radiotherapy devices market. As cancer cases continue to rise, the demand for advanced treatment options such as radiotherapy is also growing. Improved awareness, early diagnosis, and access to advanced treatment techniques are playing a critical role in addressing this expanding healthcare challenge, thereby supporting market growth.

• India recorded an estimated 14,61,427 new cancer cases in 2022, with a crude rate of 100.4 per 100,000 population. With nearly one in nine individuals at risk of developing cancer in their lifetime, the burden on the healthcare system is intensifying. This is increasing the need for effective tumor management solutions, significantly driving demand for radiotherapy devices.

• Cervical and breast cancers are among the most common cancers affecting women in India, highlighting the urgent need for improved cancer care infrastructure. A woman dies of cervical cancer every 8 minutes in the country, emphasizing the importance of early detection and timely treatment supported by advanced radiotherapy technologies.

• Breast cancer also presents a serious concern, with one death reported for every two newly diagnosed cases. This alarming ratio underscores the need for enhanced screening, preventive strategies, and access to advanced therapeutic solutions such as radiotherapy to improve survival outcomes.

• Tobacco-related diseases further contribute to the rising cancer burden, with approximately 2,500 deaths reported daily in India. As tobacco use is a major risk factor for cancers such as lung and oral cancer, the demand for effective treatment solutions, including radiotherapy, continues to grow, reinforcing the need for comprehensive cancer care systems.

Increasing Healthcare Expenditure

• Rising healthcare expenditure in India is a key factor driving the radiotherapy devices market. With increasing income levels and growing awareness about quality healthcare, individuals and households are investing more in advanced diagnostic and treatment solutions, including radiotherapy for cancer care.

• In November 2022, Indian households spent over INR 120 billion on healthcare, reflecting a strong prioritization of medical needs. This surge in spending indicates a growing willingness among the population to access better healthcare services and advanced treatment options.

• A significant portion of healthcare expenditure is contributed by both urban (42.3%) and rural (57.7%) populations, highlighting improved accessibility and utilization of healthcare services across regions. This shift is encouraging the adoption of advanced cancer treatments, including radiotherapy, even in less urbanized areas.

• Increased spending has also enabled the penetration of advanced medical technologies that were previously inaccessible. Financial support mechanisms such as insurance coverage and government initiatives like Ayushman Bharat are reducing the financial burden on patients, making high-cost treatments like radiotherapy more accessible.

• There is a growing emphasis on both preventive and curative healthcare across the country. While urban areas continue to drive demand for advanced radiotherapy devices due to better infrastructure, rural regions are witnessing gradual improvements through the development of cancer care facilities and diagnostic centers.

• Overall, rising healthcare investments and improved infrastructure are expected to bridge the gap between urban and rural healthcare access, further accelerating the adoption of radiotherapy devices and supporting market growth in India.

Download Free Sample Report

Key Market Challenges

High Cost of Radiotherapy Devices

One of the major challenges in the India radiotherapy devices market is the high cost associated with purchasing, installing, and maintaining advanced radiotherapy equipment. Modern technologies like linear accelerators, proton therapy machines, and other external beam radiation devices require significant capital investment, making them unaffordable for smaller hospitals and clinics, especially in rural and semi-urban areas. Additionally, operational costs, such as regular maintenance, software upgrades, and power consumption, further strain healthcare providers' budgets.

This financial burden is compounded by the limited insurance coverage for cancer treatments in India, which often leaves patients bearing a significant portion of the treatment cost out-of-pocket. The challenge of affordability restricts the adoption of radiotherapy devices to only well-funded, high-tier hospitals, creating disparities in access to advanced cancer treatments across different regions of the country. Addressing this challenge will require collaborative efforts between the government, healthcare providers, and device manufacturers to subsidize costs, improve financing options, and develop cost-effective radiotherapy solutions.

The affordability challenge also highlights the unequal distribution of healthcare infrastructure across India, with urban centers dominating the availability of advanced radiotherapy devices, while rural and semi-urban areas remain underserved. Despite a growing cancer burden in these regions, many healthcare facilities lack the financial capacity to invest in cutting-edge radiotherapy equipment, leaving a significant portion of the population reliant on basic or outdated treatment methods. This disparity further exacerbates health inequities, as patients from underserved areas must travel long distances to access quality cancer care, adding to their financial and emotional strain.

Key Market Trends

Technological Advancements

• Technological advancements are shaping the future of the radiotherapy devices market in India, bringing precision, efficiency, and improved outcomes to cancer treatment. Innovations such as image-guided radiotherapy (IGRT), intensity-modulated radiotherapy (IMRT), and stereotactic body radiotherapy (SBRT) have transformed traditional cancer care by enabling more targeted and personalized treatments. These advancements reduce damage to surrounding healthy tissues while delivering higher doses of radiation to tumors, enhancing treatment efficacy and minimizing side effects.

• The introduction of artificial intelligence (AI) and machine learning in radiotherapy planning is another significant trend. AI-driven systems are streamlining treatment planning and improving accuracy by analyzing complex data sets, optimizing radiation delivery, and predicting patient responses. Furthermore, proton therapy, a cutting-edge technology, is gradually gaining traction in India, offering superior precision for treating complex and pediatric cancers.

• Telemedicine and remote monitoring technologies are also making radiotherapy services more accessible, especially in underserved areas. These advancements allow specialists to collaborate remotely, ensuring that patients in remote regions can benefit from the expertise of top-tier oncologists. As India’s healthcare ecosystem continues to evolve, the adoption of these advanced technologies is not only enhancing the quality of care but also fostering greater operational efficiency within cancer treatment centers.

• The increasing focus on technological innovation by both domestic and international players in the radiotherapy devices market reflects a strong commitment to addressing the country’s growing cancer burden with state-of-the-art solutions. This trend is expected to drive further growth, making advanced cancer care more effective and accessible across India.

Segmental Insights

Type Insights

• Based on Type, External Beam Radiation Therapy Device have emerged as the fastest growing segment in the India Radiotherapy Devices Market in 2024. This is due to their versatility, effectiveness, and advancements in technology. EBRT devices, such as linear accelerators, offer non-invasive treatment options that are capable of targeting tumors with high precision while sparing surrounding healthy tissues. These devices are particularly effective for treating a wide range of cancers, including lung, breast, prostate, and head and neck cancers, which are among the most prevalent in India.

• One of the key reasons for the rapid growth of this segment is the increasing adoption of advanced EBRT techniques such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and stereotactic body radiotherapy (SBRT). These technologies provide better treatment outcomes by allowing more precise radiation delivery, reducing side effects, and improving patient quality of life. Additionally, the growing prevalence of cancer and the rising demand for effective and affordable treatment options are driving the adoption of EBRT devices across the country.

Application Insights

• Based on Application, Lung Cancer has emerged as the fastest growing segment in the India Radiotherapy Devices Market during the forecast period. This growth is primarily driven by the high prevalence of lung cancer in the country, which is significantly linked to factors such as tobacco consumption, air pollution, and occupational hazards. With lung cancer being one of the leading causes of cancer-related deaths in India, there is a growing demand for advanced radiotherapy solutions to effectively treat this condition.

• Radiotherapy is a crucial treatment modality for lung cancer, particularly in cases where surgery is not feasible or when used in combination with chemotherapy. Technological advancements such as stereotactic body radiotherapy (SBRT) and intensity-modulated radiotherapy (IMRT) have revolutionized lung cancer treatment by delivering high doses of radiation with precision, minimizing damage to surrounding healthy tissues, and improving patient outcomes.

• The increasing awareness of early detection and the rising availability of modern radiotherapy techniques in cancer care centers are also contributing to the segment's growth. Furthermore, government and private healthcare investments aimed at improving oncology infrastructure are enabling greater access to lung cancer treatments, thereby driving the demand for radiotherapy devices for this application.

Download Free Sample Report

Regional Insights

Based on Region, North India emerged as the dominating region in the India Radiotherapy Devices Market in 2024. This is due to its well-established healthcare infrastructure, higher concentration of advanced cancer treatment centers, and greater accessibility to modern radiotherapy devices. The region is home to several leading hospitals, research institutions, and oncology centers that are equipped with state-of-the-art radiotherapy technologies, including linear accelerators and proton therapy systems. This concentration of facilities ensures that patients in North India have better access to advanced cancer care compared to other regions.

Additionally, the relatively higher awareness levels about cancer diagnosis and treatment among the population in North India have driven the demand for radiotherapy devices. Urban areas within the region, such as Delhi-NCR, Chandigarh, and Lucknow, act as hubs for medical tourism, attracting patients from across the country and neighboring regions seeking advanced oncological care. The presence of renowned healthcare providers offering specialized cancer treatments further consolidates North India’s leadership in the market.

Key Market Players

• Siemens Healthcare Diagnostics Ltd.
• Elekta Medical Systems India Pvt. Ltd
• Koninklijke Philips N.V.
• Accuray Medical Equipment India Pvt. Ltd.
• Hitachi High-Tech India Pvt. Ltd.
• Varian Medical Systems
• Healthcare Global Enterprises Ltd.

Recent Development

• In August 2025, Apollo Hospitals Ahmedabad inaugurated the Varian TrueBeam 3.0 radiotherapy system, a high-end linear accelerator designed for highly precise external beam cancer treatment. This was a notable product and technology upgrade for India’s radiotherapy devices market because the TrueBeam 3.0 platform was presented as one of the most advanced LINAC systems globally, supporting more accurate targeting and potentially shorter, more efficient treatments for complex cancers.

• In December 2025, Elekta introduced Evo, its AI-powered adaptive CT-Linac, to the Indian market during AMPICON 2025 in Guwahati. The launch stood out as a breakthrough innovation because Evo combines high-definition AI-enhanced imaging with online adaptive radiotherapy, allowing clinicians to tailor treatment more precisely to each patient while also helping high-volume cancer centres improve workflow and throughput.

• In December 2025, Medanta in Gurugram launched a new Varian EDGE radiation therapy system integrated with IDENTIFY surface guidance, HyperArc, RapidArc Dynamic therapy, and functional SRS cones. This was a major device-led advancement because Medanta described it as the first installation in India with this specific combination of technologies, enabling faster dose delivery, sub-millimetric precision, and improved capability for treating brain metastases, head and neck cancers, breast cancer, and lung cancer.

• In January 2026, NTPC signed a memorandum of agreement with the Gujarat Cancer and Research Institute to fund a radiotherapy upgrade at GCRI’s Siddhpur Satellite Centre, including procurement and installation of a high-energy linear accelerator. This was an important collaboration-led development because the CSR-backed project directly supports expanded access to advanced radiotherapy equipment for patients beyond major metro centres, improving treatment capacity at a satellite cancer facility in Gujarat.

• In September 2025, BEBIG Medical is aiming to take significant steps to strengthen its presence in India, reflecting the company’s commitment to making advanced radiation therapy solutions more accessible and addressing the growing demand for high-quality cancer care. BEBIG Medical GmbH, a global leader in radiation therapy products with over 40 years of experience, has a proven track record of delivering robust, innovative technologies that achieve positive clinical outcomes in cancer treatment.

• In August 2025, Elekta announced that it would bring adaptive radiation therapy (ART) to cancer patients in India, accompanied by hands-on educational and scientific symposia designed to equip oncologists with the skills and clinical knowledge necessary to deliver precise, high-quality care. With over 1.4 million new cancer cases diagnosed annually in India, a large proportion of patients present at advanced stages. Access to advanced radiation therapy remains limited, particularly outside metropolitan areas. ART enables clinicians to adjust treatment plans during a patient’s therapy course based on daily, high-resolution imaging. This approach allows precise tumor targeting even when anatomical variations such as fluctuating bladder or bowel volumes occur. The result is improved tumor control, reduced radiation exposure to surrounding organs, and a decrease in treatment-related toxicities and side effects.

• In June 2025, Cama & Albless Hospital in Mumbai resumed radiation therapy services after a two-year hiatus, following the installation of a long-awaited linear accelerator for targeted treatment. The first patient to receive therapy was a 50-year-old woman with breast cancer. Hospital officials noted that the treatment is part of a “trial run” ahead of the official inauguration. The previous machine had served the city for over a decade before being deemed unfit for continued use, during which time it had helped thousands of women access advanced cancer care.

Report Scope

In this report, the India Radiotherapy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Radiotherapy Devices Market, By Type:

o   External Beam Radiation Therapy Device

o   Internal Beam Radiation Therapy Device

o   Others

• India Radiotherapy Devices Market, By Application:

o   Breast Cancer

o   Cervical Cancer

o   Colon and Rectum Cancers

o   Stomach Cancer

o   Lung Cancer

o   Prostate Cancer

o   Skin Cancer

o   Liver Cancer

o   Other

• India Radiotherapy Devices Market, By End User:

o   Hospitals & Clinics

o   Cancer Care Centers

o   Others

• India Radiotherapy Devices Market, By Region:

o   East India

o   West India

o   North India

o   South India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Radiotherapy Devices Market.

Available Customizations:

India Radiotherapy Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

India Radiotherapy Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]